Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
- PMID: 32165541
- PMCID: PMC7132130
- DOI: 10.1073/pnas.2002589117
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
Abstract
A novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused a large respiratory outbreak in Wuhan, China in December 2019, is currently spreading across many countries globally. Here, we show that a TMPRSS2-expressing VeroE6 cell line is highly susceptible to SARS-CoV-2 infection, making it useful for isolating and propagating SARS-CoV-2. Our results reveal that, in common with SARS- and Middle East respiratory syndrome-CoV, SARS-CoV-2 infection is enhanced by TMPRSS2.
Keywords: SARS-CoV-2; TMPRSS2; VeroE6; coronavirus; outbreak.
Copyright © 2020 the Author(s). Published by PNAS.
Conflict of interest statement
The authors declare no competing interest.
Figures
Comment in
-
Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2.Pharmacol Res. 2020 Jul;157:104853. doi: 10.1016/j.phrs.2020.104853. Epub 2020 Apr 30. Pharmacol Res. 2020. PMID: 32360584 Free PMC article. No abstract available.
Similar articles
-
Characteristics of SARS-CoV-2 Isolated from Asymptomatic Carriers in Tokyo.Jpn J Infect Dis. 2020 Jul 22;73(4):320-322. doi: 10.7883/yoken.JJID.2020.137. Epub 2020 Apr 30. Jpn J Infect Dis. 2020. PMID: 32350227 No abstract available.
-
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner.Viruses. 2020 Jun 10;12(6):629. doi: 10.3390/v12060629. Viruses. 2020. PMID: 32532094 Free PMC article.
-
Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient.Emerg Microbes Infect. 2020 Dec;9(1):991-993. doi: 10.1080/22221751.2020.1760144. Emerg Microbes Infect. 2020. PMID: 32342724 Free PMC article.
-
COVID-19: The outbreak caused by a new coronavirus.Bol Med Hosp Infant Mex. 2020;77(2):47-53. doi: 10.24875/BMHIM.20000039. Bol Med Hosp Infant Mex. 2020. PMID: 32226003 Review. English.
-
Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options.J Clin Microbiol. 2020 Apr 23;58(5):e00187-20. doi: 10.1128/JCM.00187-20. Print 2020 Apr 23. J Clin Microbiol. 2020. PMID: 32161092 Free PMC article. Review.
Cited by
-
Navigating the Landscape of B Cell Mediated Immunity and Antibody Monitoring in SARS-CoV-2 Vaccine Efficacy: Tools, Strategies and Clinical Trial Insights.Vaccines (Basel). 2024 Sep 24;12(10):1089. doi: 10.3390/vaccines12101089. Vaccines (Basel). 2024. PMID: 39460256 Free PMC article. Review.
-
Nanotraps for the containment and clearance of SARS-CoV-2.Matter. 2021 Jun 2;4(6):2059-2082. doi: 10.1016/j.matt.2021.04.005. Epub 2021 Apr 22. Matter. 2021. PMID: 33907732 Free PMC article.
-
Current and emerging diagnostic tests available for the novel COVID-19 global pandemic.AAS Open Res. 2020 Apr 24;3:8. doi: 10.12688/aasopenres.13059.1. eCollection 2020. AAS Open Res. 2020. PMID: 32537561 Free PMC article.
-
The eye: "An organ that must not be forgotten in coronavirus disease 2019 (COVID-2019) pandemic".J Optom. 2021 Apr-Jun;14(2):114-119. doi: 10.1016/j.optom.2020.07.002. Epub 2020 Jul 15. J Optom. 2021. PMID: 32763128 Free PMC article. Review.
-
MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein.Theranostics. 2021 Feb 6;11(8):3853-3867. doi: 10.7150/thno.55647. eCollection 2021. Theranostics. 2021. PMID: 33664866 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous